One Specimen. One Report. Done This Week.
Eight male-specific targets from a single urethral swab or first-void urine — chlamydia, gonorrhea, trich, Mgen, HSV-1/2, syphilis, and chancroid — reported per-target in 24–48 hours.
Sending separate orders for chlamydia, gonorrhea, Mgen, and HSV is a relic. The patient with dysuria and discharge in front of you needs one specimen and one report, with each target read independently.
Eight targets, one draw, 24–48 hours — engineered for urgent care, urology, and primary care practices that want to close the loop before the patient walks out.
The clinical weight behind this panel.
Industry statistics from public-health bodies and peer-reviewed literature — context for why this testing matters.
Reported rates underestimate true prevalence in men.
Confirmatory NAAT + resistance awareness is non-negotiable.
Figures reflect publicly reported epidemiology and clinical literature for context only. They are not performance claims for the Chaseville Labs assay. See individual citations from the U.S. Centers for Disease Control and Prevention, World Health Organization, National Institutes of Health, and peer-reviewed journals.
Conditions, syndromes & infections covered.
The clinical scenarios where this panel is the right call — built around the differential your providers are actually working through.
Bacterial STIs
3Leading cause of non-gonococcal urethritis (NGU); often asymptomatic but transmissible.
Urethritis, proctitis, and pharyngitis — drug-resistant strains are rising globally.
Persistent or recurrent urethritis after standard therapy — frequently the culprit when CT/NG are negative.
Other Genitourinary Infections
2Often asymptomatic in men but transmissible — frequently the source of female partner recurrence.
Type-specific identification of genital ulcer disease.
8 targets, resolved from a single specimen.
Each organism below is reported individually as Detected, Not Detected, or Inconclusive — grouped here by pathogen class for clinical scanability.
Targets
6 targetsCulture was built for a different century.
Multiplex real-time PCR resolves what culture and rapid antigen miss — fastidious organisms, polymicrobial infections, viruses, and resistance markers — from a single specimen.
Culture & rapid antigen
- 3–5 daysPatient empirically treated before any answer arrives
- Misses fastidious & viral organismsNo growth ≠ no infection
- Single-organism biasPolymicrobial infections under-reported
- No resistance dataSusceptibilities arrive a day later, if at all
- Specimen-quality dependentPre-treated patients culture negative
STI Panel — Men on Bio-Rad CFX384
- 24–48 hoursMost reports back the next clinical day
- 8 targets, one runBacterial, viral, fungal, and parasitic in a single multiplex
- Detects what culture can'tFastidious organisms, viruses, and polymicrobial infections, all reported individually
- Validated LDTCLIA-certified, internally controlled, per-target Detected / Not Detected reporting
Per-target results, with clinical context.
Every analyte is reported individually as Detected, Not Detected, or Inconclusive. What a Detected result means clinically depends on which category the target falls into:
Detected pathogens confirm the etiology of urethritis or proctitis and direct CDC-aligned treatment. Mycoplasma genitalium detection should prompt consideration of macrolide-resistance testing; HSV-1/2 typing supports recurrence and transmission counseling.